Evoke Pharma, Inc.
EVOK
$3.11
-$0.19-5.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.35M | -6.15M | -6.53M | -7.13M | -7.79M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.29M | 1.31M | 1.50M | 1.69M | 1.76M |
| Change in Net Operating Assets | -1.40M | -487.20K | -516.90K | -495.50K | 1.05M |
| Cash from Operations | -5.46M | -5.32M | -5.55M | -5.93M | -4.99M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.74M | 11.26M | 8.26M | 7.97M | -- |
| Repurchase of Common Stock | -200.00 | -200.00 | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -426.30K | -561.10K | -545.60K | -545.60K | -119.30K |
| Cash from Financing | 14.32M | 10.70M | 7.72M | 7.42M | -119.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.86M | 5.37M | 2.17M | 1.49M | -5.10M |